Prognostic importance of the soluble plasminogen activator receptor, suPAR, in plasma from rectal cancer patients
- 1 March 2001
- journal article
- Published by Elsevier in European Journal Of Cancer
- Vol. 37 (4) , 486-491
- https://doi.org/10.1016/s0959-8049(00)00422-6
Abstract
No abstract availableKeywords
This publication has 11 references indexed in Scilit:
- Soluble urokinase receptor released from human carcinoma cells: A plasma parameter for xenograft tumour studiesBritish Journal of Cancer, 1999
- Plasma Urokinase Receptor Levels in Patients With Colorectal Cancer: Relationship to PrognosisJNCI Journal of the National Cancer Institute, 1999
- The urokinase plasminogen activator receptor in blood from healthy individuals and patients with cancerAPMIS, 1999
- The intact urokinase receptor is required for efficient vitronectin binding: receptor cleavage prevents ligand interactionFEBS Letters, 1997
- The urokinase-type plasminogen activator system in cancer metastasis: A reviewInternational Journal of Cancer, 1997
- Improved Survival with Preoperative Radiotherapy in Resectable Rectal CancerNew England Journal of Medicine, 1997
- Urokinase plasminogen activator and urokinase plasminogen activator receptor in breast cancerInternational Journal of Cancer, 1995
- Urokinase receptor and colorectal cancer survivalThe Lancet, 1994
- Mesorectal excision for rectal cancerThe Lancet, 1993
- Impact of variability among surgeons on postoperative morbidity and mortality and ultimate survival.BMJ, 1991